Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
03. November 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16876
Articles 1 - 20 / 337508
Metaplastic Carcinoma of the Breast: A Rare Biphasic Tumour-case Report and Literature Review.
Niger Postgrad Med J
Sukumar S, Shukla S, Acharya S, Tiwari S, Awale A.
PMID: 42975235 [PubMed - indexed for MEDLINE]
Personalised Breast Cancer Therapy: Historical Perspectives, Current Practice and a Glimpse into the Near Future.
Niger Postgrad Med J
Anyanwu SN.
PMID: 42975232 [PubMed - indexed for MEDLINE]
Translating absolute risk of breast cancer into screening frequency: a framework to guide practice.
J Natl Cancer Inst
Jiang S, Bennett DL, Rosner B, Colditz GA.
PMID: 42974942 [PubMed - as supplied by publisher]
Artificial intelligence assisted genomic profiling of ovarian cancer liver metastases.
Front Genet
Sun L, Li Z, Chen S.
PMID: 42974638 [PubMed]
Residual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy-Pembrolizumab Integration.
Cancer Manag Res
Jia X, Eerdemutu, Ren Y, Yang S, Yang C, Ding Q, Lin Y.
PMID: 42974087 [PubMed]
Safety-guided selection of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: toxicity profiles, dose modification, and clinical risk-benefit considerations.
Ther Adv Drug Saf
Shrivastava N, Gaonkar SL, Shaik Mahammad F.
PMID: 42973915 [PubMed]
Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy ± bevacizumab for recurrent or metastatic cervical cancer: a systematic review and meta-analysis of randomized controlled trials.
Front Immunol
Luo R, Li M, Ma L, Huang Z.
PMID: 42973905 [PubMed - indexed for MEDLINE]
Shenqi Shiyiwei Granule for breast cancer related fatigue-centered symptom cluster: protocol of a multicenter randomized double-blind placebo-controlled trial.
Front Oncol
Li SY, Wu TT, Zhang YX, Zhao J, Hu J, Zhang GL, Yang GW.
PMID: 42973811 [PubMed]
The neuro-metabolic-immune axis in breast cancer: emerging mechanisms and subtype-specific therapeutic opportunities.
Front Immunol
Xia N, Huang R, Zhong H, Zhou Z, Wang S, Wang Z, Shen K.
PMID: 42973798 [PubMed - indexed for MEDLINE]
The impact of attachment styles and self-compassion on medication adherence in breast cancer patients: A cross-sectional study.
Health Psychol Open
Zouerami A, Kianimoghadam AS, Shojaei A.
PMID: 42973694 [PubMed]
A modified ovarian-adnexal reporting and data system ultrasound for differentiating ovarian carcinoma: integration of the risk of malignancy algorithm into the American College of Radiology's O-RADS US framework.
Front Oncol
Liu M, Li D, Jin Z.
PMID: 42973469 [PubMed]
Upregulation of NKAIN1 Predicts Poor Prognosis and Shapes Immune Infiltration in Uterine Corpus Endometrial Carcinoma: An Integrated Bioinformatic and Experimental Study.
Anticancer Agents Med Chem
Chang R, Wu Y, Cui A, Jiang L, Jia Q.
PMID: 42973342 [PubMed - as supplied by publisher]
Long-Term Predictive Value of MRI Radiomics in Identifying Patients with Metastasis-Free Breast Cancer Over a 100-Month Follow-Up Period: A retrospective, observational study.
Curr Med Imaging
Zhao YS, Ji Y, Li YB, Wang YH, Ma XX, Wang JB, Wang P, Lu H.
PMID: 42973335 [PubMed - as supplied by publisher]
Preventive Effects of Mānuka Honey and a Honey Sugar Analogue on Breast Cancer Development: Modulation of Oxidative Stress and AKT/mTOR Signaling in a Rat Model.
Curr Top Med Chem
Usama M, Abas AM, Abd Elhameed HAH.
PMID: 42973300 [PubMed - as supplied by publisher]
A multi-reader multi-case study comparing Breast Cancer Reading Efficiency and Accuracy in Screening with Tomosynthesis versus AI-assisted mammography.
Br J Radiol
Ning SGS, Hao D, Chandrasegan G, Yuan Zheng L, Chua W, Ong HY, Seah E, Ge S, Lau S, Wong YM, Jagmohan P, Trivedi H, Brown-Mulry B, Isaac RS, Gichoya JW, Mansuri A, Feng M, Tai BC, Hartman M.
PMID: 42973140 [PubMed - as supplied by publisher]
Concentration-Based Short-Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 Trial.
J Surg Oncol
Batista TP, de Barros ABD, Carneiro VCG, Tancredi R, Badiglian-Filho L, Costa RLR, Lopes A, Sarmento BJQ, Leão CS.
PMID: 42973117 [PubMed - as supplied by publisher]
Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers.
Nucl Med Commun
Hatipoglu F, Senmevsim O, Kahraman EG, Tasli F.
PMID: 42973046 [PubMed - as supplied by publisher]
Reminder recall is associated with higher mammogram uptake among overdue repeat screeners: an exploratory telephone survey within a randomized trial.
BMC Med
Lucky SS, Li W, Ow SGW, Loh L, Tan JH, Goh BC, Lee SC.
PMID: 42972567 [PubMed - indexed for MEDLINE]
Multicenter development and validation of a serum microRNA-based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control study.
Breast Cancer Res
Yamaguchi A, Kawanishi K, Ishii K, Fukui Y, Shimizu H, Kawashima M, Otomo R, Taniguchi S, Hirai M, Tsuji W, Takahara S, Yamashiro H, Yanai H, Moriguchi Y, Tsuyuki S, Nishie M, Suwa H, Masuda N, Toi M.
PMID: 42972452 [PubMed - indexed for MEDLINE]
Explainable machine learning and multi-layer transcriptomic analysis identify and validate prognostic biomarkers for breast cancer survival.
BMC Med Genomics
Oguz O, Ayd, Gungor BB, Goksuluk D.
PMID: 42972374 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 337508
Page 1 of 16876
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy